Seurico™ Vein Varicose Relief Spray

Varicose veins are affecting most of usApproximately 23% of the adult population in the United States suffers from lower extremity varicose veins, with 6% being severe cases of chronic venous disease (CVD) presenting with symptoms such as venous edema, skin changes, active or healed venous ulcers, etc. Varicose veins, venous ulcers, and related complications not only cause chronic pain, disability, decreased quality of life, reduced workdays, and early retirement but also impose a significant economic burden on patients and society. There are approximately 11 million male and 22 million female varicose vein patients in the US aged 40 to 80, with over 2 million being severe CVD cases. The direct medical costs of CVD are estimated to range between $150 million and $1 billion annually, while in the UK, approximately 2% of the national healthcare budget (around $1 billion) is allocated to the treatment of lower limb ulcers  What our customers say about Seurico™"I have been dealing with var